T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
Cancer Research and Treatment. 2020;52(3):747-763 
Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
Vaccine. 2010;28(6):1468-1476
Engineered Fusion Hybrid Vaccine of IL-18 Gene-Modified Tumor Cells and Dendritic Cells Induces Enhanced Antitumor Immunity
Cancer Biotherapy and Radiopharmaceuticals. 2004;19(3):322-330
Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity
Leukemia Research. 2002;26(8):757-763
Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity
The Vaccine Book. 2016;581-596
721. Enhanced Antitumor Cellular Immunity Induced by a Novel HPV-16 DNA Vaccine Encoding a E6/E7 Fusion Consensus Protein
Molecular Therapy. 2008;16:S269
Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7
Vaccine. 2000;18(25):2886-2894
Monocytes as a Cellular Vaccine Platform to Induce Antitumor Immunity
Methods in Molecular Biology. 2021;627-647
Triple Antigen mRNA-Loaded Langerhans-Type Dendritic Cell Vaccine after Autotransplant for Multiple Myeloma Induces Antitumor Immunity
Transplantation and Cellular Therapy. 2022;28(3):S225-S226
Genetically modified CELO viruses; vector for use in e.g. cytokine-mediated gene therapy, or as an antitumor etc. recombinant vaccine
Vaccine. 1998;16(7):757